StockData
PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc. (PMVP) stock

PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.22+0.00 (0.00%)

Close on Nov 18, 2026Market cap $65.22MP/E –Yield –

PMV Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for PMV Pharmaceuticals

PMV Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More PMV Pharmaceuticals figures

See a number that looks wrong?